David Norton

David York Norton is currently Chairman at Global Alliance for TB Drug Development since 2023, Chairman at Syneos Health NC LLC since 2015, Independent Director at Compass Pathways Plc since 2024, Director at Forepont Capital LLC since 2023, and Director at COMPASS Pathfinder Holdings Ltd. since 2018.
Former positions include Chairman-Global Pharmaceuticals at Johnson & Johnson from 2009 to 2011, Chairman at American Foundation for Suicide Prevention from 2000 to 2016, Chairman at INC Research Holdings, Inc. from 2016 to 2017, Group Chairman-Europe, Middle East & Africa at Pharmaceuticals Group, LLC, Independent Director at Savient Pharmaceuticals, Inc. from 2013 to 2014, Director at VIVUS, Inc. from 2013 to 2020, Director at Global Alliance for TB Drug Development from 2012 to 2019, Independent Director at Keenova Therapeutics PLC from 2017 to 2022, Director at Pharmaceutical Research & Manufacturers of America from 2007 to 2010, Director at Alliance for Aging Research from 2001 to 2010, Director at INC Research, Inc. from 2015 to 2017, and President at Janssen Pharmaceuticals, Inc. from 1997 to 1998.
Education includes undergraduate studies at London College of Communication and Control Data Institute.